Authors: Atencio, IA Avanzini, JB Johnson, D Neuteboom, S Vaillancourt, MT Nielsen, LL Hajian, G Sutjipto, S Sugarman, BJ Philopena, J McAllister, DL Beltran, JC Nodelman, M Ramachandra, M Wills, KN

Citation: Ia. Atencio et al., Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment, MOL THER, 4(1), 2001, pp. 5-12

Authors: Wills, KN Atencio, IA Avanzini, JB Neuteboom, S Phelan, A Philopena, J Sutjipto, S Vaillancourt, MT Wen, VF Ralston, RO Johnson, DE

Citation: Kn. Wills et al., Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus, J VIROLOGY, 75(18), 2001, pp. 8733-8741

Authors: Howe, JA Demers, GW Johnson, DE Neugebauer, SEA Perry, ST Vaillancourt, MT Faha, B

Citation: Ja. Howe et al., Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy, MOL THER, 2(5), 2000, pp. 485-495

Authors: Cheyney, IW Neuteboom, STC Vaillancourt, MT Ramachandra, M Bookstein, R

Citation: Iw. Cheyney et al., Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27(Kip1) into cyclin E/CDK2 complexes, CANCER RES, 59(10), 1999, pp. 2318-2323